The Board of Directors in its meeting held on May 11, 2026, inter alia, considered and approved the financial results, declaration dividend, re-appointment of statutory auditor, re-appointment ....
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Archean Chemical Industries reported standalone FY26 revenue of Rs. 104,154 lakhs (up 2.7% from Rs. 101,379 lakhs), but PAT declined 16.5% to Rs. 15,437 lakhs due to higher finance costs (doubled to Rs. 1,772 lakhs) and exceptional cyclone loss of Rs. 4,018 lakhs. Consolidated PAT fell 35% to Rs. 10,541 lakhs. The Board recommended a 125% dividend (Rs. 2.50 per share) and reappointed PKF Sridhar & Santhanam LLP as statutory auditors for a second 4-year term. The company also disclosed an Income Tax search operation in September 2025 (impact not quantifiable) and continued land lease renewal uncertainty (expired July 2018). Key investments include strategic stakes in SiC semiconductor (Clas-SiC, UK) and zinc-bromide battery technology (Offgrid Energy Labs, USA).
Significant PAT decline and increased debt levels are concerns for shareholders. The cyclone loss and tax department scrutiny add uncertainty, though dividend declaration and new semiconductor investments signal some confidence. Shareholders should monitor the pending land lease renewal and income tax assessment outcomes.